Hong Kong authorities have reported the death of a chronically ill man two days after he received a COVID-19 vaccine and say that it is too early to conclude whether the vaccine was related to his death.
Subscribe now for unlimited access.
$0/
(min cost $0)
or signup to continue reading
The man's death happened less than a week after Hong Kong began its vaccination program for priority and at-risk groups in the city.
The 63-year-old man was inoculated with the COVID-19 vaccine on February 26 at a government-designated vaccination site and developed shortness of breath two days later on February 28.
The man then admitted himself to a hospital but died the same day, according to a statement from health authorities late on Tuesday night.
While the statement did not specify which vaccine the man was inoculated with, the vaccination program in Hong Kong currently only uses shots from Chinese biopharmaceutical company Sinovac.
Hong Kong health authorities said that the man's death is under investigation.
"At the moment, the causal relationship with the vaccination could not be ascertained," the statement said.
The patient was suffering from chronic and respiratory diseases, according to a statement by the Queen Elizabeth Hospital in Hong Kong, where he was admitted after receiving the vaccination.
An expert panel will look into the matter and its findings will be released "in a timely manner," authorities said.
More than 40,000 people in Hong Kong have received the vaccine since Friday, when the vaccination drive began.
More than 254,000 people have registered to take the vaccine so far.
Australian Associated Press
